Around one in ten women have high blood pressure in pregnancy. This is potentially serious, with risks to the woman and her baby. Whilst maternal deaths from high blood pressure in pregnancy are now rare in the UK, blood pressure problems in pregnancy still cause many stillbirths and early births. Studies have shown that women of Black and Asian backgrounds are more likely to have worse pregnancy outcomes when blood pressure problems in pregnancy develop. This study aims to: i) describe the burden of disease of high blood pressure in pregnancy amongst babies admitted to neonatal units on a national scale. ii) investigate outcomes for babies born to women with high blood pressure in pregnancy admitted to UK neonatal units across maternal ethnic groups. To complete this study, we will use the National Neonatal Research Database, which holds population-level data for all babies admitted to neonatal units (where unwell babies receive care) in the UK. We will look at records of babies admitted to neonatal units in England and Wales between 2012 and 2020. The records will include information on over half a million babies and their mothers. We will assess how many babies admitted to neonatal units were born to women who had high blood pressure in pregnancy. We will report the outcomes of these babies, and how they compare to babies born to women without high blood pressure in pregnancy. We will analyse whether outcomes for babies born to women with high blood pressure in pregnancy varies according to maternal ethnicity, and investigate what may be driving differences we find.
Study Aims This study aims to: * quantify the proportion of all babies admitted to neonatal units born to women with a hypertensive disorder of pregnancy * describe the national neonatal morbidity, mortality and resource use of babies admitted to neonatal units born to women with a hypertensive disorder of pregnancy * examine ethnic disparities in neonatal outcomes of babies admitted to neonatal units born to women with hypertensive disorders of pregnancy. The National Neonatal Research Database (NNRD) The NNRD is an approved research database constituting real-world prospective clinical data extracted from point-of-care neonatal electronic health records with complete coverage of infants admitted for neonatal care to National Health Service (NHS) neonatal units in England and Wales (since 2012) and Scotland (since 2015). A defined data extract of approximately 450 items (the Neonatal Data Set) is transmitted quarterly to the Neonatal Data Analysis Unit at Imperial College London for data linkage and cleaning prior to entry into the NNRD. To date, the NNRD contains data for over a million babies (approximately 80,000 babies annually). High completeness and accuracy (\>95%) of neonatal data held in the NNRD has been confirmed by formal comparison with a multicentre, randomised placebo-controlled trial. Study Design This study is a secondary analysis of an existing national electronic health record population cohort using anonymised, routinely recorded clinical data from the National Neonatal Research Database (NNRD). There will be no new patients recruited and there will be no changes made to patient care. The research team will work with NNRD data analysts to extract anonymised data from the NNRD. A cohort of babies born to women with a hypertensive disorder of pregnancy (HDP) will be defined based on records of maternal medical problems prior to pregnancy, obstetrics problems during pregnancy, medications given during labour and neonatal discharge diagnoses. The morbidity, mortality and health resource use of this cohort will be described in depth. This cohort will also be compared to a cohort of babies born to women without a hypertensive disorder of pregnancy. The HDP cohort will also be stratified by maternal ethnicity to investigate disparities in outcomes.
Study Type
OBSERVATIONAL
Enrollment
823,957
Imperial College London
London, United Kingdom
Survival to discharge from neonatal care
Survival to discharge from neonatal care
Time frame: From birth to discharge or death, assessed up to 1 year
Primary recorded reason for neonatal unit admission
Primary recorded reason for neonatal unit admission
Time frame: From birth to discharge or death, assessed up to 1 year
Length of stay in neonatal unit
Length of stay in neonatal unit
Time frame: From birth to discharge or death, assessed up to 1 year
Number of days of intensive care
Number of days of intensive care
Time frame: From birth to discharge or death, assessed up to 1 year
Survival to discharge from neonatal care without comorbidity
Survival to discharge from neonatal care without comorbidity
Time frame: From birth to discharge or death, assessed up to 1 year
Cause of death
Cause of death
Time frame: From birth to discharge or death, assessed up to 1 year
Age at death
Age at death
Time frame: From birth to discharge or death, assessed up to 1 year
Discharge weight SDS (standard deviation score)
Discharge weight SDS (standard deviation score)
Time frame: From birth to discharge or death, assessed up to 1 year
Birthweight centile (z-score)
Birthweight centile (z-score)
Time frame: From birth to discharge or death, assessed up to 1 year
Clinical diagnoses potential specific to hypertensive disorders of pregnancy
Fetal growth restriction/intrauterine growth restriction, hypoglycaemia
Time frame: From birth to discharge or death, assessed up to 1 year
General neonatal complications
Brain injury on imaging, necrotising enterocolitis, sepsis, jaundice, GI perforation
Time frame: From birth to discharge or death, assessed up to 1 year
Preterm complications
Chronic lung disease/bronchopulmonary dysplasia, retinopathy of prematurity
Time frame: From birth to discharge or death, assessed up to 1 year
Number of days of high-dependancy care
Number of days of high-dependancy care
Time frame: From birth to discharge or death, assessed up to 1 year
Number of days of special care
Number of days of special care
Time frame: From birth to discharge or death, assessed up to 1 year
Number of days of invasive respiratory support
Number of days of invasive respiratory support
Time frame: From birth to discharge or death, assessed up to 1 year
Number of days of non-invasive respiratory support
Number of days of non-invasive respiratory support
Time frame: From birth to discharge or death, assessed up to 1 year
Transfusion of blood products
Transfusion of blood products
Time frame: From birth to discharge or death, assessed up to 1 year
Number of days of parenteral nutrition
Number of days of parenteral nutrition
Time frame: From birth to discharge or death, assessed up to 1 year
Method of feeding (number of days of each e.g. NG, breast etc)
Method of feeding (number of days of each e.g. NG, breast etc)
Time frame: From birth to discharge or death, assessed up to 1 year
Type of feeding (number of days of each e.g. breastmilk, formula etc)
Type of feeding (number of days of each e.g. breastmilk, formula etc)
Time frame: From birth to discharge or death, assessed up to 1 year
Number of days nil by mouth
Number of days nil by mouth
Time frame: From birth to discharge or death, assessed up to 1 year
Line type(s)
Line type(s)
Time frame: From birth to discharge or death, assessed up to 1 year
Surfactant administered
Surfactant administered
Time frame: From birth to discharge or death, assessed up to 1 year
Surfactant administered on first day
Surfactant administered on first day
Time frame: From birth to discharge or death, assessed up to 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.